Profusa, Inc.

Nasdaq:PFSAOTC:NVACW

Surgical & Medical Instruments & Apparatus·NEW YORK, NY

CFO

Knechtel Fred S.

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

$1.2M

FY 2024

EPS (Diluted)

$0.12

FY 2024

Stock Price

$0.89

-0.6%

2026-03-09

52W Range

$0.85 – $180.00

P/E Ratio

7.4x

Market Cap

$58.1M

Cash

$4,519

FY 2024

Total Debt

$200,000

FY 2023

Net Debt

$195,481

FY 2023

Enterprise Value

$58.3M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

Revenue

—

Adj. EBITDA

—

Net Income

$1.2M

FY 2024

EPS (Diluted)

$0.12

FY 2024

Stock Price

$0.89

-0.6%

2026-03-09

52W Range

$0.85 – $180.00

P/E Ratio

7.4x

Market Cap

$58.1M

Cash

$4,519

FY 2024

Total Debt

$200,000

FY 2023

Net Debt

$195,481

FY 2023

Enterprise Value

$58.3M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—